Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Wilkins, A. & Parker, C. Treating prostate cancer with radiotherapy. Nat. Rev. Clin. Oncol. 7, 583–589 (2010).
2. Pilepich, M. V. et al. Phase III trial of androgen suppression using goserelin in unfavourable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of the Radiation Therapy Oncology Group Protocol 85–31. J. Clin. Oncol. 15, 1013–1021 (1997).
3. Pilepich, M. V. et al. Phase III radiation therapy oncology group (RTOG) trial 86–10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate. Int. J. Radiat. Oncol. Biol. Phys. 50, 1243–1252 (2001).
4. Jones, C. U. et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer. N. Engl. J. Med. 365, 107–118 (2011).
5. D'Amico, A. V., Chen, M.-H., Renshaw, A. A., Loffredo, M. & Kantoff, P. W. Androgen suppression and radiation vs radiation alone for prostate cancer. JAMA 299, 289–295 (2008).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献